SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
MERLO LARRY J

(Last) (First) (Middle)
ONE CVS DRIVE

(Street)
WOONSOCKET RI 02895-

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CVS CAREMARK CORP [ CVS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President and CEO
3. Date of Earliest Transaction (Month/Day/Year)
07/02/2012
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/02/2012 M 80,679 A $30.035 228,059.5269 D
Common Stock 07/02/2012 S (1) 80,679 D $46.95 (2) 147,380.5269 D
Common Stock 07/02/2012 M 80,680 A $30.035 228,060.5269 D
Common Stock 07/02/2012 S (1) 80,680 D $46.96 (3) 147,380.5269 D
Common Stock 333,126.6339 I By Trust As Beneficiary
Common Stock (restricted) 288,004 D
ESOP Common Stock 6,239.5451 I By ESOP
Stock Unit 278,877.9157 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option $30.035 07/02/2012 M 80,679 04/03/2007 (4) 04/03/2013 Common Stock 80,679 $0 80,680 D
Stock Option $30.035 07/02/2012 M 80,680 04/03/2007 (4) 04/03/2013 Common Stock 80,680 $0 0 D
Phantom Stock Credits $1 (5) (6) (7) (6) (7) Common Stock 5,205.5266 5,205.5266 D
Stock Option $34.42 04/02/2008 (8) 04/02/2014 Common Stock 136,089 136,089 D
Stock Option $41.17 04/01/2009 (9) 04/01/2015 Common Stock 144,144 144,144 D
Stock Option $28.1 04/01/2010 (10) 04/01/2016 Common Stock 185,572 185,572 D
Stock Option $36.23 04/01/2011 (11) 04/01/2017 Common Stock 152,988 152,988 D
Stock Option $34.96 04/01/2012 (12) 04/01/2018 Common Stock 241,150 241,150 D
Stock Option $45.07 04/02/2013 (13) 04/02/2019 Common Stock 332,736 332,736 D
Explanation of Responses:
1. All sales were effected pursuant to a Rule 10b5-1 plan.
2. Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $46.76 and $47.03 per share.
3. Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging from $46.74 and $47.03 per share.
4. Option became exercisable in three equal annual installments, commencing 4/3/2007.
5. Each share credit is equivalent to one share; 1-for-1 conversion.
6. Reflects 2002 and 2003 year end company match share credits of 33 and 27, respectively, under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
7. Reflects year end company match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such timee as has been elected by the reporting person.
8. Option became exercisable in three equal annual installments, commencing 4/2/2008.
9. Option became exercisable in three equal annual installments, commencing 4/1/2009.
10. Option became exercisable in three equal annual installments, commencing 4/1/2010.
11. Option became exercisable in three equal annual installments, commencing 4/1/2011.
12. Option became exercisable in four equal annual installments, commencing 4/1/2012.
13. Option becomes exercisable in four equal annual installments, commencing 4/2/2013.
Larry J. Merlo 07/03/2012
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.